CJC-1295 DAC
Also known as Drug Affinity Complex CJC-1295
Long-acting GHRH analogue with a drug affinity complex.
- Category
- muscle
- Route
- subq
- Documented dose
- 1000–2000 mcg
- Typical frequency
- Once or twice weekly
- Cycle
- 12 weeks on, 4 off
- Half-life
- ~6-8 days
- Common vial sizes
- 2 mg, 5 mg
- Regulatory status
- Not approved for human use.
What it does
The same growth-hormone-releasing peptide with an added carrier (DAC) that keeps it in the bloodstream for days instead of minutes, giving a raised baseline of growth hormone and IGF-1 from one or two shots a week. What people look into it for: • Steady, longer-lasting support for recovery and repair • Lean muscle and fat-loss support over a longer cycle • Convenience — far fewer injections than short-acting versions The trade-off is that it flattens the body's natural pulsing rhythm, which some people prefer to keep intact.
Mechanism
Albumin-binding DAC extends half-life of the GHRH analogue, raising GH bleed levels.
Storage — lyophilised
Refrigerate 2-8C, protect from light.
Storage — reconstituted
Refrigerate 2-8C, use within ~28 days.
Reconstitution notes
Add 2 ml bacteriostatic water to a 2 mg vial for 10 mcg per unit.
Commonly stacked with
- Ipamorelin
Commonly reported side effects
- Water retention
- Joint aches
- Carpal tunnel symptoms
- Fatigue
Contraindications noted
- Active malignancy
- Pregnancy or breastfeeding
- Uncontrolled diabetes
Research notes
Sustained GH elevation is less physiologic than pulsatile dosing; monitor IGF-1 where possible.
Track this properly
Work out syringe units with the free calculator, or set up a full schedule in about a minute.
Reference information only, not medical advice. See our medical disclaimer.